Pfizer CEO Albert Bourla said that two doses of the Pfizer/BioNTech vaccine are “not enough” protection against the Omicron variant of SARS-CoV-2.
Bourla’s comments on his vaccine’s effectiveness came Monday during the 40th Annual J.P. Morgan Healthcare Conference, which he addressed in an interview-style format. The pharmaceutical CEO said a booster shot offers better protection but warned that that protection may wane, highlighting the need for a new version of the vaccine that protects against the Omicron variant.
“Omicron is a way more challenging target, so the two doses are not enough for Omicron,” Bourla said. “The third dose of the current vaccine is providing good protection against death and decent protection against hospitalization. So, most of the people that they are ending up in hospital [with